Cost-effectiveness of HPV 16, 18 vaccination in Brazil (Q44396284)

2 December 2017

Cost-effectiveness of HPV 16, 18 vaccination in Brazil (English)

1 reference

cost-effectiveness analysis

2 December 2017

0 references

1 reference

5

1 reference

2 December 2017

9

1 reference

2 December 2017

8

Silvia de Sanjosé

0 references

Jeremy Goldhaber-Fiebert

4

object named as

Jeremy D Goldhaber-Fiebert

0 references

Sue Goldie

1

object named as

Sue J Goldie

1 reference

Francesc Xavier Bosch José

2 December 2017

7

object named as

F Xavier Bosch

1 reference

2 December 2017

Jane J Kim

2

1 reference

2 December 2017

Katie Kobus

3

1 reference

2 December 2017

Meredith K H O'shea

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

15 June 2007

1 reference

2 December 2017

1 reference

2 December 2017

25

1 reference

2 December 2017

33

1 reference

2 December 2017

6257-6270

1 reference

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Chapter 2: The burden of HPV-related cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Chapter 1: HPV in the etiology of human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Chapter 8: Screening for cervical cancer in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Cost-effectiveness of cervical-cancer screening in five developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Multiparameter Calibration of a Natural History Model of Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Prevalence and determinants of HPV infection among Colombian women with normal cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Evaluation of alternative methods of cervical cancer screening for resource-poor settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

CHAPTER 7 Methods for detection of HPV infection and its clinical utility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Estimating the cost of cervical cancer screening in five developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Estudio farmacoeconómico del tratamiento antibiótico de las agudizaciones de la bronquitis crónica y la EPOC en Latinoamérica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Integrated approach to women's health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Estimated costs of treatment of benign prostate hyperplasia in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.058

10.1016/J.VACCINE.2007.05.058

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference